...
首页> 外文期刊>European journal of gastroenterology and hepatology >Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls.
【24h】

Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls.

机译:成本效益分析和增加的成本效益比率:使用和陷阱。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Cost-effectiveness analysis is a formal method of comparing alternative medical interventions with regard to their resource utilization (costs) and outcomes (effectiveness). The incremental cost-effectiveness ratio is an informative measure generated from such an analysis and represents the ratio of the difference in cost between two medical interventions to the difference in outcomes between the two interventions. Thus, the incremental cost-effectiveness ratio summarizes the additional cost per unit of health benefit gained in switching from one medical intervention to another. Although incremental cost-effectiveness ratios have limitations, when used in the proper context, these ratios serve as one of the important tools needed to help guide decisions about allocating scarce resources across competing medical programmes.
机译:成本效益分析是一种比较替代医学干预措施的资源利用(成本)和结果(有效性)的正式方法。成本效益比增量是从这种分析中得出的信息量度,代表两种医疗干预措施之间的成本差异与两种干预措施之间的结果差异之比。因此,增加的成本效益比总结了从一种医疗干预转向另一种医疗干预所获得的每单位健康收益的额外成本。尽管增量成本效益比率有局限性,但在适当的情况下使用时,这些比率是帮助指导有关在竞争性医疗计划之间分配稀缺资源的决策的重要工具之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号